JUDGE SETS PHARMASCIENCE'S VALUE, FINDS EXPERTS' APPRAISALS UNREALISTIC Gray v. Cytokine Pharmasciences | Secondary Sources | Westlaw

JUDGE SETS PHARMASCIENCE'S VALUE, FINDS EXPERTS' APPRAISALS UNREALISTIC Gray v. Cytokine Pharmasciences | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, JUDGE SETS PHARMASCIENCE'S VALUE, FINDS EXPERTS' APPRAISALS UNREALISTIC Gray v. Cytokine Pharmasciences, Secondary Sources
Skip Page Header

JUDGE SETS PHARMASCIENCE'S VALUE, FINDS EXPERTS' APPRAISALS UNREALISTIC Gray v. Cytokine Pharmasciences

16 No. 19 ANDECLR 6Andrews Delaware Corporate Litigation Reporter (Approx. 2 pages)

JUDGE SETS PHARMASCIENCE'S VALUE, FINDS EXPERTS' APPRAISALS UNREALISTIC Gray v. Cytokine Pharmasciences

16 No. 19 ANDECLR 6Andrews Delaware Corporate Litigation Reporter (Approx. 2 pages)

16 No. 19 Andrews Del. Corp. Litig. Rep. 6
Andrews Delaware Corporate Litigation Reporter
May 28, 2002
Appraisal:
Copyright (c) 2002 Andrews Publications

JUDGE SETS PHARMASCIENCE'S VALUE, FINDS EXPERTS' APPRAISALS UNREALISTIC

Gray v. Cytokine Pharmasciences

In resolving an appraisal challenge to what shareholders of Pharmasciences Inc. received for their stock in a merger with Cytokine Networks Inc., Vice Chancellor Stephen Lamb said he was thankful for the independent pre-merger assessment of PI done...
End of Document© 2023 Thomson Reuters. No claim to original U.S. Government Works.